CytoSorbents Reports Third Quarter 2025 Financial Results and Provides Business Update

CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit ...

Rekor Systems Reports Record Third Quarter 2025 Financial Results

Company Achieves Third Consecutive Quarter of Positive ResultsHighlights: Record Quarterly Revenue: $14.2 million.Record Gross Margin: Adjusted ...

Xos Extends Profitability Streak with Strong Q3 2025 Performance and Positive Operating Cash Flow

Delivered 130 units and generated $16.5 million in revenueAchieved 15.3% Gross Margin and a second consecutive quarter of positive free cash flow ...
Le Lézard

Kodiak Sciences Announces Recent Business Highlights and Third Quarter 2025 Financial Results

Kodiak Sciences Inc. , today reported recent business highlights and financial results for the third quarter ended September 30, 2025. "Kodiak Sciences has entered a period of strong, sustained ...
Le Lézard

Profound Medical Reports Strong Third Quarter 2025 Financial Results

Profound Medical Corp. ("Profound" or the "Company"), a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for the ablation of diseased ...